Long-acting injectable cabotegravir for HIV prevention found safe in pregnancy
Long-acting injectable cabotegravir (CAB-LA) was safe and well-tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women. The analysis of outcomes ...
Jul 23, 2024
0
1